Release Date: 03/02/09 10:05 Summary: Supplementary Prospectus Non Renounceable Rights Issue Price Sensitive: Yes Download Document 126.8KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market